US$ 28.49
glp 1 inhibitor Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Glucagon-like peptide-1 - Wikipedia
Description
Okada, Y
doi: 10.1001/jamainternmed.2013.2720

GLP-1 Receptor Agonists for the Treatment of Obesity: Role as a Promising Approach

2.8% said they used GLP-1s for ten months

The switch depends on your remaining beta cell function, current glucose control, overall health status, and treatment goals

Classification and Pharmacokinetics of DPP-4 Inhibitors: 4.1
